Alfuzosin Hydrochloride
NDC Package 33261-994-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Alfuzosin Hydrochloride is extended-release tablets are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Marketed by Aidarex Pharmaceuticals Llc, this product is identified by NDC 33261-994 and is authorized under FDA application ANDA079057.

Identification & Billing

NDC Package Code
33261-994-90
Package Description
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code
33261-994
11-Digit Billing Format
33261099490
RxNorm Crosswalk
  • RxCUI: 861132 - alfuzosin HCl 10 MG 24HR Extended Release Oral Tablet
  • RxCUI: 861132 - 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet
  • RxCUI: 861132 - alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Alfuzosin Hydrochloride
Dosage Form
-
Usage Information
Alfuzosin hydrochloride extended-release tablets are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.

Regulatory & Marketing

Labeler Name
Aidarex Pharmaceuticals Llc
FDA Application #
ANDA079057
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-22-2011
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (33261-994). Click a package code to view its specific billing and regulatory data.

33261-994-30
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
33261-994-60
60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 33261-994-90 identifies a specific commercial package of 90 tablet, extended release in 1 bottle, plastic of Alfuzosin Hydrochloride, labeled by Aidarex Pharmaceuticals Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aidarex Pharmaceuticals Llc on November 22, 2011. The current certification is valid through December 31, 2019.

How is this Aidarex Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 33261099490. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
33261-994-90
11-Digit CMS (5-4-2)
33261-0994-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.